Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 5/2017

01-05-2017 | Erratum

Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types

Authors: Jeong Eun Kim, Joung-Soon Jang, Jae-Weon Kim, Sung Yong Lee, Chi-Heum Cho, Myung-Ah Lee, Do-Jin Kim, Myung-Ju Ahn, Kil Yeon Lee, Sun Jin Sym, Myong Choel Lim, Hun Jung, Cho Eun Kim, Kyung Wan Min

Published in: Supportive Care in Cancer | Issue 5/2017

Login to get access

Excerpt

Erratum to: Support Care Cancer (2017) 25:801–809 …
Metadata
Title
Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types
Authors
Jeong Eun Kim
Joung-Soon Jang
Jae-Weon Kim
Sung Yong Lee
Chi-Heum Cho
Myung-Ah Lee
Do-Jin Kim
Myung-Ju Ahn
Kil Yeon Lee
Sun Jin Sym
Myong Choel Lim
Hun Jung
Cho Eun Kim
Kyung Wan Min
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3608-9

Other articles of this Issue 5/2017

Supportive Care in Cancer 5/2017 Go to the issue

Original Article

Triathlon training for women breast cancer survivors: feasibility and initial efficacy

Review Article

A systematic review of the impact of pain on overall survival in patients with cancer

Original Article

Quality of life of older African American breast cancer survivors: a population-based study

Original Article

Clinical research participation among adolescent and young adults at an NCI-designated Comprehensive Cancer Center and affiliated pediatric hospital

Original Article

Association of worry about cancer to benefit finding and functioning in long-term cancer survivors

Original Article

Quality of Working Life of cancer survivors: associations with health- and work-related variables
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits